Catabasis Pharmaceuticals, Inc. carries a market capitalization of 234.86M, placing it among publicly traded companies globally.
| Market Cap | 234.86M |
| Enterprise Value | N/A |
Catabasis Pharmaceuticals, Inc.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 8.23, while the 200-day moving average is 3.74.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 8.23 |
| 200-Day Moving Average | 3.74 |
| Average Volume (20 Days) | N/A |
Catabasis Pharmaceuticals, Inc.'s most recent stock split took place on August 19, 2021 with a 6:1 split ratio.
| Last Split Date | 8/19/2021 |
| Split Ratio | 6:1 |